0001493152-23-032998.txt : 20230919 0001493152-23-032998.hdr.sgml : 20230919 20230919083017 ACCESSION NUMBER: 0001493152-23-032998 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230919 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35570 FILM NUMBER: 231262554 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 19, 2023

SONNET BIOTHERAPEUTICS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-35570

20-2932652

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

100 Overlook Center, Suite 102
Princeton, New Jersey		08540
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (609) 375-2227

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 Par Value		SONN		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 19, 2023, Sonnet BioTherapeutics Holdings, Inc. (the “Company,” “we” or “us”) issued a press release announcing that on September 18, 2023, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, the Company’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2), and that the matter is now closed. A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

As previously reported, on March 23, 2023, the Company received a letter from Nasdaq’s Listing Qualifications Staff indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company was not in compliance with the Minimum Bid Price Requirement, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Notice”). Pursuant to the Notice, Nasdaq had given the Company 180 calendar days, or until September 19, 2023, to regain compliance with the Minimum Bid Price Requirement.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Exhibit

99.1		Press Release dated September 19, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Sonnet BioTherapeutics Holdings, Inc.
	a Delaware corporation
	(Registrant)

Date: September 19, 2023	By:	/s/ Pankaj Mohan, Ph.D.
	Name:	Pankaj Mohan, Ph.D.
	Title:	Chief Executive Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance

PRINCETON, NJ / ACCESSWIRE / September 19, 2023 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that it has received formal notice from the Listing Qualifications staff of The Nasdaq Stock Market indicating that Sonnet has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

To regain compliance with the Rule, the Company’s common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, which was achieved on September 15, 2023. As a result, the listing matter has been closed.

About Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bispecific action. Known as F_HAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Sonnet’s F_HAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. F_HAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the timing of an IND submission, the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential, “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Sonnet BioTherapeutics Investor Contact

Jack Yauch

Solebury Strategic Communications

862-754-1024

jyauch@soleburystrat.com

SOURCE: Sonnet BioTherapeutics, Inc.

EX-101.SCH 3 sonn-20230919.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sonn-20230919_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 sonn-20230919_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Sep. 19, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Sep. 19, 2023
Entity File Number	001-35570
Entity Registrant Name	SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Entity Central Index Key	0001106838
Entity Tax Identification Number	20-2932652
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	100 Overlook Center
Entity Address, Address Line Two	Suite 102
Entity Address, City or Town	Princeton
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08540
City Area Code	(609)
Local Phone Number	375-2227
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.0001 Par Value
Trading Symbol	SONN
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001106838 2023-09-19 2023-09-19 iso4217:USD shares iso4217:USD shares 0001106838 false 8-K 2023-09-19 SONNET BIOTHERAPEUTICS HOLDINGS, INC. DE 001-35570 20-2932652 100 Overlook Center Suite 102 Princeton NJ 08540 (609) 375-2227 false false false false Common Stock, $0.0001 Par Value SONN NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://sonnetbio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm sonn-20230919.xsd sonn-20230919_lab.xml sonn-20230919_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "SONN", "nsuri": "http://sonnetbio.com/20230919", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "sonn-20230919.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "sonn-20230919_lab.xml" ] }, "presentationLink": { "local": [ "sonn-20230919_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://sonnetbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001493152-23-032998-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-032998-xbrl.zip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end